Evidence map›Paper›PMID 37050880›Full record

ArticleClinical trials (London, England)2023

Lessons learned from conducting the first cancer care delivery trial in the Alliance for Clinical Trials in Oncology (Alliance A191402CD).

Joel E Pacyna, Amylou C Dueck, George J Chang, Selina Chow, Electra D Paskett, Simon Kim, Jon C Tilburt

Open access · greenAbstract read
In one paragraph

Article in Clinical trials (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Joel E PacynaBiomedical Ethics Research Program, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-3103-7805
Amylou C DueckAlliance Statistics and Data Center, Mayo Clinic, Scottsdale, AZ, USA.ORCID 0000-0002-9912-1085
George J ChangDepartment of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Selina ChowAlliance Protocol Operations Office, University of Chicago, Chicago, IL, USA.
Electra D PaskettThe Ohio State University College of Medicine, Columbus, OH, USA.
Simon KimDivision of Urology, Anschutz Medical Campus, University of Colorado, Aurora, CO, USA.
Jon C TilburtBiomedical Ethics Research Program, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic in Arizona · USMayo Clinic in Florida · USThe Ohio State University · USThe University of Texas MD Anderson Cancer Center · USUniversity of Chicago · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Collaborations and NCORP Collective ManagementUG1CA189823 · NCI · MAYO CLINIC ROCHESTER · PI Evanthia Galanis, Olwen Hahn · 2014 to 2026
$120.6M
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1UG1CA233329 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KELLY K HUNT, CHELSEA Camille PINNIX · 2019 to 2026
$11.1M
OSU as a Network Lead Academic Participating Site for the NCI NCTNUG1CA233331 · NCI · OHIO STATE UNIVERSITY · PI John L. Hays, Dwight H. Owen · 2019 to 2026
$8.9M
NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1 (funded extension)UG1CA232760 · NCI · MAYO CLINIC ROCHESTER · PI Judy Caroline Boughey, Aaron Scott Mansfield · 2019 to 2026
$8.5M
NCI National Clinical Trials Network - Lead Academic Participating SiteUG1CA233324 · NCI · UNIVERSITY OF COLORADO DENVER · PI ANTHONY D ELIAS · 2019 to 2026
$5.2M
Decision Aids to Address Prostate Cancer Disparities in Minority MenR01MD008934 · NIMHD · MAYO CLINIC ROCHESTER · PI KIM, SIMON P, TILBURT, JON C · 2014 to 2018
$1.9M
NCI NIH HHS UG1 CA189823NCI NIH HHS UG1 CA232760NCI NIH HHS UG1 CA233324NCI NIH HHS UG1 CA233329NCI NIH HHS UG1 CA233331NIMHD NIH HHS R01 MD008934
6 · The paper itself

Abstract

introductionTesting healthcare delivery interventions in rigorous clinical trials is a critical step in improving patient care, but conducting multisite randomized clinical trials to test the effect of care delivery interventions has unique challenges and requires foresight and planning.

methodsWe conducted the first care delivery trial (A191402CD) in the Alliance for Clinical Trials in Oncology, a National Cancer Institute Community Oncology Research Program research base, which tested the effectiveness of two different decision aids for supporting shared decision-making about prostate cancer treatment. Our experience illustrates the kind of challenges that confront care delivery researchers as they seek to test interventions to improve the experiences of patients.

resultsLessons learned include the following: cluster-randomized designs introduce complexity; workflow disruption can discourage site participation; evidence-based methods may not always be sufficient.

conclusionWe conclude with the following recommendations: assessing feasibility requires special rigor; relationships and interpersonal dynamics must be leveraged. Our experiences may inform future care delivery research.

Indexed as

Medical OncologyProstatic NeoplasmsClinical Trials as TopicDelivery of Health CareHumansMaleCluster-randomized designhealthcare delivery researchprostate cancershared decision-making

Identifiers

PMID37050880
PMCPMC10523847
OpenAlexW4365443864

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.